US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Simplify US Small Cap PLUS Income ETF

22.11

0.0000

Volume:- -

Turnover:- -

Market Cap:2.76M

PE:- -

High:22.11

Open:22.11

Low:22.11

Close:22.11

52wk High:25.00

52wk Low:16.85

Shares:125.00K

Float Shares:125.00K

Volume Ratio:- -

T/O Rate:- -

Dividend:0.00

Dividend Rate:0.00%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)

Buy Rating on SCYNEXIS: Promising Potential of SCY-247 Amid Market Volatility

SCYNEXIS Announces Positive Results from a Phase 1, Single Ascending Dose and Multiple Ascending Dose Study of its Second-Generation Fungerp (SCY-247)

SCYNEXIS Announces Multiple Presentations Highlighting Data from its Second-Generation Fungerp, SCY-247, at the 12th Congress on Trends in Medical Mycology (TIMM-12)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SCY"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SCY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCY\",,,,,undefined,":{"symbol":"SCY","market":"US","secType":"STK","nameCN":"Simplify US Small Cap PLUS Income ETF","latestPrice":22.11,"timestamp":1770152400000,"preClose":22.11,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":125001,"shares":125001,"eps":0,"marketStatus":"Market Closed","change":0,"latestTime":"02-03 16:00:00 EST","open":22.11,"high":22.11,"low":22.11,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"AMEX","adjPreClose":22.11,"sharesOutstanding":125001,"nav":22.11,"aum":2763392.63,"dividendRate":0.000045,"bidAskSpread":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCY\",,,,,undefined,":{"symbol":"SCY","floatShares":125001,"roa":"--","roe":"--","lyrEps":0,"shares":125001,"dividePrice":0.001,"high":22.11,"amplitude":0,"preClose":22.11,"low":22.11,"week52Low":16.85,"pbRate":"--","week52High":25,"institutionHeld":0,"latestPrice":22.11,"eps":0,"divideRate":0.000045,"volume":0,"delay":0,"ttmEps":0,"open":22.11,"prevYearClose":22.2529,"prevWeekClose":22.11,"prevMonthClose":20.2696,"prevQuarterClose":19.5697},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-27","symbol":"SCY","reason":null,"defaultRemindTime":1748352600000,"announcedDate":"2025-05-02","type":"delisting","dateTimestamp":1748318400000},{"date":"2025-03-26","symbol":"SCY","amount":0.1,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Simplify US Small Cap PLUS Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-31","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-03-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCY\",market:\"US\",,,undefined,":[{"executeDate":"2025-03-26","recordDate":"2025-03-26","paymentDate":"2025-03-31","value":0.1,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCY\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SCY\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606671906","title":"SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2606671906","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606671906?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:00","pubTimestamp":1769605200,"startTime":"0","endTime":"0","summary":"This cross-disciplinary meeting highlights the latest discoveries, technologies and translational strategies driving the next generation of antimicrobial solutionsJERSEY CITY, N.J., Jan.  28, 2026  (G","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/28/3227560/0/en/SCYNEXIS-Announces-Presentations-Highlighting-the-Potent-Antifungal-Activity-of-its-Second-Generation-Fungerp-SCY-247-Against-Drug-Resistant-Fungi-at-the-Inaugural-Interdisciplinar.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASM","VVC","SCY","IDSA","BK4007","SCYX","BK4188"],"gpt_icon":0},{"id":"2572551952","title":"Buy Rating on SCYNEXIS: Promising Potential of SCY-247 Amid Market Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2572551952","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572551952?lang=en_us&edition=fundamental","pubTime":"2025-10-02 02:15","pubTimestamp":1759342517,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jason McCarthy from Maxim Group reiterated a Buy rating on SCYNEXIS, with a price target of $4.00. Jason McCarthy h...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-on-scynexis-promising-potential-of-scy-247-amid-market-volatility-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-on-scynexis-promising-potential-of-scy-247-amid-market-volatility-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SCY"],"gpt_icon":0},{"id":"2571347882","title":"SCYNEXIS Announces Positive Results from a Phase 1, Single Ascending Dose and Multiple Ascending Dose Study of its Second-Generation Fungerp (SCY-247)","url":"https://stock-news.laohu8.com/highlight/detail?id=2571347882","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571347882?lang=en_us&edition=fundamental","pubTime":"2025-09-30 20:00","pubTimestamp":1759233600,"startTime":"0","endTime":"0","summary":"No safety concerns or dose limiting toxicities observed SCY-247 was able to achieve target exposures at doses lower than our first-generation fungerp Safety, tolerability, and pharmacokinetic profile ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/30/3158537/0/en/SCYNEXIS-Announces-Positive-Results-from-a-Phase-1-Single-Ascending-Dose-and-Multiple-Ascending-Dose-Study-of-its-Second-Generation-Fungerp-SCY-247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VVC","SCY","SCYX"],"gpt_icon":0},{"id":"2564374002","title":"SCYNEXIS Announces Multiple Presentations Highlighting Data from its Second-Generation Fungerp, SCY-247, at the 12th Congress on Trends in Medical Mycology (TIMM-12)","url":"https://stock-news.laohu8.com/highlight/detail?id=2564374002","media":"GlobeNewswire","labels":["productRelease","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564374002?lang=en_us&edition=fundamental","pubTime":"2025-09-04 20:30","pubTimestamp":1756989000,"startTime":"0","endTime":"0","summary":"Oral presentation will feature data demonstrating SCY-247 in vitro activity against C. auris strains, including isolates with mutations commonly associated with echinocandin-resistanceAdditional poste","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/04/3144512/0/en/SCYNEXIS-Announces-Multiple-Presentations-Highlighting-Data-from-its-Second-Generation-Fungerp-SCY-247-at-the-12th-Congress-on-Trends-in-Medical-Mycology-TIMM-12.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CET","SCY","VVC","BK4007","SCYX"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SCY\",params:#limit:6,delay:false,,,undefined,":[]}}